Jun 23, 2025
Onco-Innovations Limited
‹ Beyond Medical Technologies Reports Robust H1 2025 Progress, Sets Stage for Republic Technologies
Beyond Medical Technologies Closes First Tranche of Convertible Note Financing for $1.68 Million and Announces Rebranding to Republic Technologies ›
About
Investor Relations
News
Insights
Contact
Subscribe
CSE: DOCT
FSE: 7FM0
OTCQB: DOCKF
